Recent RNA Stock Price | RNA Stock Predictions | |
$24.36 | +96.35% |
$47.83 |
Recent RNA Analyst Ratings Breakdown, Making RNA Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 6 | 6 | 5 | 5 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.14 | 1.14 | 1.17 | 1.17 |
For the RNA stock predictions from the analysts covering Avidity Biosciences Inc, we have collected all of the individual RNA stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering RNA (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since RNA stock predictions may vary widely, another useful metric to consider is the median RNA stock prediction, which represents the price at which half of the analysts
made RNA stock predictions that were higher and half made RNA stock predictions that were lower. This makes for a different take on the RNA stock predictions out there, as compared to average or mean.
And that median across all the individual RNA stock predictions was: $44.0 as of 2024-04-29.
The very highest of the RNA stock predictions for one year price target was $71.0, while the very lowest of the RNA stock predictions in the analyst group was
$33.0 (with a standard deviation of $15.302). Get the latest Zacks research report on RNA — FREE
Find out: RNA next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
NI Stock Predictions
GBIO Stock Predictions
MMM Stock Predictions
AQUA Stock Predictions
CIR Stock Predictions
NKSH Stock Predictions
FBMS Stock Predictions
MIST Stock Predictions
PASG Stock Predictions
|
|
Strong Buy (3.86 out of 4) 75th percentile
(ranked higher than approx. 75% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |